Dr. Michelle N. Johnson, MD

Dr. Johnson practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Johnson's NPI, 1073521696, was assigned on August 3, 2006. Dr. Johnson graduated from Weill Cornell Medicine in 1992. Dr. Johnson holds New York license 194904.

Dr. Johnson's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Johnson's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dr. Johnson is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Memorial Cardiopulmonary Group. Dmand AI also links Dr. Johnson to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Johnson practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Johnson's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Johnson is licensed in New York.

Dmand AI lists atrial fibrillation and flutter, chronic hypertension, coronary artery disease, heart failure, heart valve disorders, high cholesterol, pulmonary heart disease and varicose veins among the conditions Dr. Johnson treats.

CMS data shows 4,881 Medicare services from Dr. Johnson across 8 procedure codes in 2024, for 3,536 Medicare patients. Medicare paid $54,212 for them.

CMS counts 3,536 Medicare patients who saw Dr. Johnson in 2024. The largest group is 65 to 74, with 1,600 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Johnson's median patient age at 69, with 51% women.

In 2024, Dr. Johnson wrote 328 Medicare Part D claims for 79 patients. 83% of them were for generic drugs. CMS names the drug for 245 of them, across 10 drugs with 11 or more claims each, at $349,401 in total drug cost. In 2023, CMS named 220 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Johnson for performance year 2024, reported as part of a group. Dr. Johnson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Johnson as offering telehealth.

Dmand AI links 9 papers to Dr. Johnson, published from 2021 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Cardiotoxicity and Ethnicity. Dr. Johnson has published most often in JACC CardioOncol. Dr. Johnson's most frequent co-authors are Robert S. Copeland-Halperin, MD, Chau T. Dang, MD and Jennifer E. Liu, MD.

CMS Open Payments shows 3 general payments to Dr. Johnson from 3 drug and device companies from 2017 to 2020. Food and beverage make up the largest share, 100% of the total. Medtronic Vascular, Inc. paid the most, $90.

Dmand AI lists 1 award for Dr. Johnson.

Dr. Johnson graduated from Weill Cornell Medicine in 1992.

Dr. Johnson is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.